Anne Kiltie is Professor of Experimental Clinical Oncology and a CRUK Senior Clinical Group Leader at the CRUK/MRC Oxford Institute for Radiation Oncology.  Her scientific interests are in the development of biomarkers to aid patient treatment in muscle-invasive bladder cancer and the development of radiosensitisers which have minimal effects on normal tissues, for use in an increasingly elderly bladder cancer population. She is also an Honorary Consultant Clinical Oncologist at Oxford University Hospitals NHS Trust, treating patients with bladder cancer. Between 2001 and 2009 she was a Senior Lecturer/Honorary Consultant Clinical Oncologist at Leeds Institute of Molecular Medicine and St James' University Hospital, Leeds.  She was previously a Clinical Research Fellow at the Imperial Cancer Research Fund (ICRF) Clare Hall Laboratories in Hertfordshire. Her clinical training was undertaken at the Christie Hospital, Manchester, and Cookridge Hospital, Leeds. She studied Medicine at Sidney Sussex College, Cambridge, and Clinical Medicine at Balliol College, Oxford.